 |
|
Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare Beneficiaries
A National Survey 1 Year Before the Medicare Drug Benefit
Stephen B. Soumerai, ScD;
Marsha Pierre-Jacques, BA;
Fang Zhang, PhD;
Dennis Ross-Degnan, ScD;
Alyce S. Adams, PhD;
Jerry Gurwitz, MD;
Gerald Adler, MPhil;
Dana Gelb Safran, ScD
Arch Intern Med. 2006;166:1829-1835.
Background Prior to implementation of the Medicare drug benefit, we estimated the prevalence of cost-related medication nonadherence (CRN) among Medicare enrollees, including elderly and nonelderly disabled beneficiaries.
Methods In the fall of 2004, detailed measures of CRN (skipping or reducing doses or not filling prescriptions because of cost) were added to the Medicare Current Beneficiary Survey. We examined the prevalence of CRN nationally and by Medicare eligibility subgroups (elderly vs nonelderly disabled beneficiaries), drug coverage status, socioeconomic status, self-rated health, and number of chronic medical conditions.
Results In a national sample of 13 835 noninstitutionalized Medicare enrollees, 29% of the disabled and 13% of the elderly beneficiaries reported CRN; those in fair to poor health with multiple comorbidities and without coverage were most at risk. Among the disabled enrollees with 4 or more morbidities, 52% (95% confidence interval [CI], 43.3%-60.3%) without drug coverage skipped prescriptions or doses compared with 26% (95% CI, 17.7%-34.8%) with Medicaid drug coverage. Those with partial drug coverage through Medigap policies or Medicare health maintenance organizations reported intermediate rates of CRN. The adjusted odds ratio of CRN among disabled enrollees in poor (vs good) health was 3.9 (95% CI, 1.7-9.2), whereas for those with 4 or more (vs <4) comorbidities, the odds ratio of CRN was 2.7 (95% CI, 1.7-4.1).
Conclusions One year before Medicare Part D implementation, Medicare beneficiaries reported high rates of CRN. Rates are highest among nonelderly disabled beneficiaries, but among both elderly and disabled beneficiaries, CRN is exacerbated by poor health, multiple morbidities, and limited drug coverage. Given the high cost sharing under Part D, it is important to closely monitor CRN in high-risk subgroups.
Author Affiliations: Department of Ambulatory Care and Prevention, Harvard Medical School & Harvard Pilgrim Health Care, Boston, Mass (Drs Soumerai, Zhang, Ross-Degnan, and Adams and Ms Pierre-Jacques); Meyers Primary Care Institute and University of Massachusetts Medical School, Worcester (Dr Gurwitz); Centers for Medicare and Medicaid Services, US Department of Health and Human Services, Baltimore, Md (Mr Adler); and The Health Institute at Tufts–New England Medical Center and Tufts University School of Medicine, Boston (Dr Safran).
RELATED ARTICLES
Improving Medication Adherence: Challenges for Physicians, Payers, and Policy Makers
Patrick J. O’Connor
Arch Intern Med. 2006;166(17):1802-1804.
EXTRACT
| FULL TEXT
The Care Transitions Intervention: Results of a Randomized Controlled Trial
Eric A. Coleman, Carla Parry, Sandra Chalmers, and Sung-joon Min
Arch Intern Med. 2006;166(17):1822-1828.
ABSTRACT
| FULL TEXT
Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
P. Michael Ho, John S. Rumsfeld, Frederick A. Masoudi, David L. McClure, Mary E. Plomondon, John F. Steiner, and David J. Magid
Arch Intern Med. 2006;166(17):1836-1841.
ABSTRACT
| FULL TEXT
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
P. Michael Ho, John A. Spertus, Frederick A. Masoudi, Kimberly J. Reid, Eric D. Peterson, David J. Magid, Harlan M. Krumholz, and John S. Rumsfeld
Arch Intern Med. 2006;166(17):1842-1847.
ABSTRACT
| FULL TEXT
Improved Therapeutic Monitoring With Several Interventions: A Randomized Trial
Adrianne C. Feldstein, David H. Smith, Nancy Perrin, Xiuhai Yang, Mary Rix, Marsha A. Raebel, David J. Magid, Steven R. Simon, and Stephen B. Soumerai
Arch Intern Med. 2006;166(17):1848-1854.
ABSTRACT
| FULL TEXT
Physician Communication When Prescribing New Medications
Derjung M. Tarn, John Heritage, Debora A. Paterniti, Ron D. Hays, Richard L. Kravitz, and Neil S. Wenger
Arch Intern Med. 2006;166(17):1855-1862.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
General Health Status and Adherence to Antiretroviral Therapy
Cardarelli et al.
J Int Assoc Physicians AIDS Care (Chic Ill) 2008;7:123-129.
ABSTRACT
Model for medication therapy management in a university clinic
Kliethermes et al.
Am J Health Syst Pharm 2008;65:844-856.
ABSTRACT
| FULL TEXT
Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D
Madden et al.
JAMA 2008;299:1922-1928.
ABSTRACT
| FULL TEXT
Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs
Hsu et al.
JAMA 2008;299:1929-1936.
ABSTRACT
| FULL TEXT
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures
Demers et al.
CMAJ 2008;178:405-409.
ABSTRACT
| FULL TEXT
Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With Diabetes: The Translating Research Into Action for Diabetes Study
Tseng et al.
Diabetes Care 2008;31:261-266.
ABSTRACT
| FULL TEXT
The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT
Impact of Primary Care Patient Visits on Racial and Ethnic Disparities in Preventive Care in the United States
Fiscella and Holt
J Am Board Fam Med 2007;20:587-597.
ABSTRACT
| FULL TEXT
Identifying Widely Covered Drugs and Drug Coverage Variation Among Medicare Part D Formularies
Tseng et al.
JAMA 2007;297:2596-2602.
ABSTRACT
| FULL TEXT
Depression and Cost-Related Medication Nonadherence in Medicare Beneficiaries
Bambauer et al.
Arch Gen Psychiatry 2007;64:602-608.
ABSTRACT
| FULL TEXT
Improving medication adherence: challenges for physicians, payers, and policy makers.
O'Connor
Arch Intern Med 2006;166:1802-1804.
FULL TEXT
|
